ClinicalTrials.Veeva

Menu

Comparison of the Therapeutic Effects of VR and Hysteroscope + Laparoscope in the Treatment of Cesarean Scar Diverticula

S

Shanghai First Maternity and Infant Hospital

Status

Unknown

Conditions

Cesarean Scar Diverticula

Study type

Observational

Funder types

Other

Identifiers

NCT02933216
CSD-002

Details and patient eligibility

About

Cesarean scar diverticula (CSD) is a novel recognized cause of postmenstrual abnormal uterine bleeding in women. No clinical guidelines have been issued for the management of CSD. Currently, several limited surgical management procedures for CSD have been reported, such as hysteroscopic combined with laparoscopic excision (abbreviated as hysteroscope + laparoscope) and vaginal repair of CSD (abbreviated as VR). However, which management can achieve better clinical effects remains unknown. Therefore, this prospective study is designed to compare the therapeutic effects between VR and hysteroscope + laparoscope in the treatment of CSD.

Enrollment

100 estimated patients

Sex

Female

Ages

20 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients are younger than 40.
  2. Clearly diagnosed with CSD.
  3. Experiencing clinical features of abnormal uterine bleeding, prolonged menstrual flow (the duration of menstruation is more than 7 days).
  4. The thickness of the remaining muscular layer of CSD was less than 3 mm.
  5. The women are at least 20 years old with singleton pregnancies and had undergone a cesarean delivery after at least 37 weeks of gestation.
  6. The medicine conservative treatment is invalid.
  7. Refusing or use birth control pills contraindications.
  8. No serious medical problems (important viscera function in the normal range).
  9. No uterine fibroids, endometriosis, adenomyosis, and patients with ovarian cysts.
  10. No gynaecology or other malignant tumors.
  11. Sign the informed consent.

Exclusion criteria

  1. Over the age of 40;
  2. Indefinite diagnosis.
  3. The absence of clinical manifestations of CSD.
  4. The presence of menstrual irregularities before cesarean delivery.
  5. Coagulation disorders.
  6. Malignant tumors.
  7. With severe medical problems (severe liver disease, kidney disease, respiratory diseases, heart disease or uncontrolled diabetes, epilepsy, etc., dysfunction of important organs).
  8. Known chronic inflammatory diseases, any other uterine diseases (such as uterine fibroids, endometriosis and adenomyosis), uterine surgery except cesarean section.
  9. Use of intrauterine devices.
  10. Unwilling to comply with the research plan.

Trial design

100 participants in 2 patient groups

VR
Description:
The CSD patients are received treatment of vaginal repair.
hysteroscope + laparoscope
Description:
The CSD patients are received treatment of hysteroscopic combined with laparoscopic excision.

Trial contacts and locations

1

Loading...

Central trial contact

Xipeng Wang, M.D., Ph.D.,; Xiaoqian Yang, M.D., Ph.D.,

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems